SC Filed 2022-09-27 Event — SEC 0000947871-22-001017 →

ORBIMED ADVISORS LLC → ALPINE IMMUNE SCIENCES, INC.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

16 13D/G filings on this issuer

15 other filings besides this one

Filer Track Record

131 filings by this filer

130 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on ALPINE IMMUNE SCIENCES, INC.

Filed	Form	Filer	Stake	Shares
2022-09-27	SC	Decheng Capital China Life Sciences USD Fund III, L.P.	—	—	view →
2022-09-27	SC	Alpine ImmunoSciences, L.P.	—	—	view →
2022-02-15	SC	Frazier Life Sciences VIII, L.P.	—	—	view →
2021-11-12	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-09-21	SC	Frazier Life Sciences VIII, L.P.	—	—	view →
2021-09-21	SC	Decheng Capital China Life Sciences USD Fund III, L.P.	—	—	view →
2021-09-21	SC	Alpine ImmunoSciences, L.P.	—	—	view →
2020-12-22	SC	Alpine ImmunoSciences, L.P.	—	—	view →
2020-08-03	SC	Alpine ImmunoSciences, L.P.	—	—	view →
2020-08-03	SC	Decheng Capital China Life Sciences USD Fund III, L.P.	—	—	view →
2019-01-23	SC	Alpine ImmunoSciences, L.P.	—	—	view →
2019-01-23	SC	ORBIMED ADVISORS LLC	—	—	view →
2019-01-23	SC	Frazier Life Sciences VIII, L.P.	—	—	view →
2018-01-26	SC	ORBIMED ADVISORS LLC	—	—	view →
2018-01-26	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by ORBIMED ADVISORS LLC

Filed	Form	Issuer	Stake	Shares
2026-04-10	SCHEDULE 13D/A	Adicet Bio, Inc. ACET	8.80%	844,787	view →
2026-01-27	SCHEDULE	Corvus Pharmaceuticals, Inc. CRVS	10.30%	8,609,091	view →
2025-10-10	SCHEDULE	Adicet Bio, Inc. ACET	9.60%	14,772,598	view →
2025-09-30	SCHEDULE	MBX Biosciences, Inc. MBX	9.00%	4,002,887	view →
2025-07-21	SCHEDULE	Passage BIO, Inc. PASG	7.82%	243,878	view →
2025-05-14	SCHEDULE	Corvus Pharmaceuticals, Inc. CRVS	12.20%	9,785,423	view →
2025-04-11	SCHEDULE	Compass Therapeutics, Inc. CMPX	11.00%	15,219,994	view →
2025-01-29	SCHEDULE	Traws Pharma, Inc. TRAW	19.90%	760,824	view →
2024-11-12	SC	Third Harmonic Bio, Inc.	—	—	view →
2024-10-25	SC	TELA Bio, Inc. TELA	—	—	view →
2024-10-01	SC	TELA Bio, Inc. TELA	—	—	view →
2024-07-02	SC	TELA Bio, Inc. TELA	—	—	view →
2024-06-20	SC	Disc Medicine, Inc. IRON	—	—	view →
2024-04-12	SC	Passage BIO, Inc. PASG	—	—	view →
2024-01-29	SC	Adicet Bio, Inc. ACET	—	—	view →
2023-11-01	SC	Apollomics Inc. APLMW	—	—	view →
2023-10-04	SC	SYNLOGIC, INC. SYBX	—	—	view →
2023-10-02	SC	Apollomics Inc. APLMW	—	—	view →
2023-09-05	SC	Galecto, Inc. DMRA	—	—	view →
2023-08-11	SC	Gracell Biotechnologies Inc.	—	—	view →

Showing 20 of 130

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →